Tech Company Financing Transactions
Aristea Therapeutics Funding Round
Aristea Therapeutics closed a $15 million Series A funding round on 12/19/2018. Backers included Novo Ventures.
Transaction Overview
Company Name
Announced On
12/19/2018
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors
Novo Ventures (Tiba Aynechi)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Diego, CA 22434
USA
San Diego, CA 22434
USA
Phone
Undisclosed
Website
Email Address
Overview
Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases. The Aristea team is leveraging its broad industry expertise and proven success in drug development to form synergistic partnerships and build a pipeline of novel drugs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Mackay
Chief Medical Officer
Nihar Bhakta
VP - Bus. Development
John Montana
VP - Operations
Deanne Reid
Browse more venture capital transactions:
Prev: 12/19/2018: Cybeats venture capital transaction
Next: 12/19/2018: Tridiuum venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs